BOTHELL, Wash., March 3 /PRNewswire-FirstCall/ Cardiac Science Corporation(Nasdaq: CSCX), a global leader in automated external defibrillator (AED) anddiagnostic cardiac monitoring devices, announced today that it will releaseits fourth quarter 2009 financial results on Thursday, March 11, 2010 aftermarket close. The Company has scheduled a conference call with analysts andinvestors for 4:30 p.m. Eastern Time. During the call, Cardiac Sciencemanagement will discuss the financial results for the fourth quarter as wellas the current business outlook.
To access the conference call, please dial 888.549.7880 and referenceconference ID 4252130. Callers outside the U.S. can dial 480.629.9868. Thecall will also be webcast live at www.cardiacscience.com. An audio replay ofthe call will be available for 7 days following the call at 800.406.7325 forU.S. callers or 303.590.3030 for those calling from outside the U.S. Thepassword required to access the replay is 4252130#. An archived webcast willalso be available at www.cardiacscience.com for 90 days.
About Cardiac Science
Cardiac Science develops, manufactures, and markets a family of advanceddiagnostic and therapeutic cardiology devices and systems, including automatedexternal defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiacstress treadmill and systems, Holter monitoring systems, hospitaldefibrillators, vital signs monitors, cardiac rehabilitation telemetrysystems, and cardiology data management systems (informatics) that connectwith hospital information (HIS), electronic medical record (EMR), and otherinformation systems. The company sells a variety of related products andconsumables and provides a portfolio of training, maintenance, and supportservices. Cardiac Science, the successor to the cardiac businesses thatestablished the trusted Burdick(R), HeartCentrix(R), Powerheart(R), andQuinton(R) brands, is headquartered in Bothell, Washington. With customers inmore than 100 countries worldwide, the company has operations in NorthAmerica, Europe, and Asia. For information, call 425.402.2000 or visithttp://www.cardiacscience.com.
For updates and information on worldwide defibrillation and cardiacmonitoring, find us on the Cardiac Science blog athttp://www.cardiacscience.com/blog, Twitter athttp://twitter.com/cardiacscience, Facebook at http://budurl.com/CSonFB, andYouTube at http://budurl.com/CSonYT.
CSCX-FFor more information, Company Contact: Investor Contact: Mike Matysik Matt Clawson Cardiac Science Corporation Allen & Caron Senior Vice President and CFO 949.474.4300 425.402.2009 email@example.com Media Contact: Christopher Gale EVC Group Inc. 646.201.5431 203.570.4681 firstname.lastname@example.org LOGO: http://www.cardiacscience.com/images/main_logo.gif
SOURCE Cardiac Science Corporation